脊髓损伤
脊髓
医学
刺激
功能性电刺激
安慰剂
皮质脊髓束
物理医学与康复
神经科学
麻醉
运动皮层
心理学
内科学
磁共振成像
替代医学
病理
磁共振弥散成像
放射科
作者
Bing Chen,Siddharth Gaikwad,Robert Powell,Hang Jin Jo,Allison Kessler,David Chen,C J Heckman,Linda Jones,James K. Guest,Jonathan R. Wolpaw,Martin Oudega,Andrew R. Blight,Mónica A. Pérez
出处
期刊:Brain
[Oxford University Press]
日期:2025-03-24
标识
DOI:10.1093/brain/awaf099
摘要
Combinatorial approaches targeting multiple aspects of spinal cord injury (SCI) pathophysiology are needed to maximize functional recovery. We hypothesized that strengthening corticospinal synapses via Hebbian stimulation and increasing neuronal transmission with 4-aminopyridine (4-AP, a potassium blocker) could accelerate locomotor recovery in individuals with chronic SCI. Participants were randomly assigned to receive 10 mg of 4-AP or placebo, where both groups followed with 60-min of Hebbian stimulation targeting corticospinal-motoneuronal synapses supplying leg muscles involved in locomotion and 60-min of standard exercise rehabilitation for 40 sessions over 8-14 weeks. During Hebbian stimulation, 720 paired pulses were delivered to elicit corticospinal action potentials via electrical stimulation of the thoracic spine, ensuring volleys reached the spinal cord 1-2 milliseconds before motoneurons were retrogradely activated through bilateral electrical stimulation of the femoral, common peroneal, and posterior tibial nerves (targeting the quadriceps femoris, tibialis anterior, and soleus muscles, respectively). Results showed that participants who received 4-AP exhibited significantly greater improvements in walking speed and endurance, corticospinal transmission, and light touch sensation compared to those who received the placebo. The minimal clinically important difference in walking speed and endurance was achieved after 20 sessions in the 4-AP group, but was not consistently reached in the placebo group. Although walking continued to improve in both groups over the course of 40 sessions, the 4-AP group demonstrated significantly greater progress. Improvement in the 4-AP group was still present twelve months later. These findings suggest that 4-AP represents a strategy to potentiate and accelerate Hebbian stimulation effects on motor recovery in individuals with chronic SCI.
科研通智能强力驱动
Strongly Powered by AbleSci AI